Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
May-2017 Volume 13 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2017 Volume 13 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice

  • Authors:
    • Xu‑Zheng Chen
    • Zhi‑Yun Cao
    • You‑Quan Zhang
    • Jin‑Nong Li
    • Lian‑Ming Liao
    • Jian Du
  • View Affiliations / Copyright

    Affiliations: Center of Oncology, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China, Department of Clinical Laboratory, The Second Affiliated Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, P.R. China, Department of Pharmacognosy, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China
  • Pages: 3261-3268
    |
    Published online on: March 13, 2017
       https://doi.org/10.3892/ol.2017.5849
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Fuzheng Qingjie (FZQJ) is a polyherbal Chinese medicine that has previously been implemented as an adjuvant therapy for gastrointestinal cancer. The present study investigated whether FZQJ is able to potentiate the anticancer effect of cyclophosphamide (CTX). Hepatoma 22 tumor‑bearing mice were randomly divided into a vehicle group, CTX group, FZQJ group and combination (CTX+FZQJ) group. In addition, untreated mice without H22 cells served as blank controls. Seven days post‑treatment, the mice were sacrificed and the tumors were weighed. Blood cells were evaluated using an automatic hemocytometer analyzer and flow cytometer. The expression levels of interleukin (IL)‑2 and tumor necrosis factor (TNF)‑α were evaluated using a radioimmunoassay. Apoptotic cells were observed using a terminal deoxynucleotidyl transferase dUTP nick‑end labeling assay. Alanine transaminase, aspartate aminotransferase, blood urea nitrogen and creatinine were examined using an automatic biochemical analyzer. The results demonstrated that the tumor inhibitory rate and apoptosis index were higher in the combination group, compared with those in the CTX group. Notably, FZQJ was able to alleviate CTX‑induced decreases in the numbers of white blood cells and platelets, CD3+ and CD4+ T lymphocyte subsets, and the concentration of hemoglobin, body weight and thymus index, and increase serum TNF-α and IL-2 levels without overt hepatorenal toxicity. These results suggest that FZQJ granules may enhance the anticancer effect of CTX, in addition to alleviating the side effects.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Bosch FX, Ribes J, Cléries R and Díaz M: Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 9:191–211, v. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL and Inoue M: Hepatitis B and C virus infection and hepatocellular carcinoma in China: A review of epidemiology and control measures. J Epidemiol. 21:401–416. 2011. View Article : Google Scholar : PubMed/NCBI

3 

European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Wörns MA, Weinmann A, Schuchmann M and Galle PR: Systemic therapies in hepatocellular carcinoma. Dig Dis. 27:175–188. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Konkimalla VB and Efferth T: Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol. 116:207–210. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Wang Z, Li J, Ji Y, An P, Zhang S and Li Z: Traditional herbal medicine: A review of potential of inhibitory hepatocellular carcinoma in basic research and clinical trial. Evid Based Complement Alternat Med. 2013:2689632013.PubMed/NCBI

7 

Zhang J and Shan BE: Recent advances on traditional Chinese medicine in immunoregulation and anticancer mechanism. Chin J Immunol. 22:385–388. 2006.(In Chinese).

8 

Wu QX and Xu ZY: Advances on traditional Chinese medicine in myelosuppression. Zhejiang J Tradit Chin Med. 45:618–621. 2010.(In Chinese).

9 

Shi Y, Wang CH and Gong XG: Apoptosis-inducing effects of two anthraquinones from Hedyotis diffusa WILLD. Biol Pharm Bull. 31:1075–1078. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Lin SY, Shen CY, Jiang JP, Wu LQ, Dai TY, Qian WB and Meng HT: Apoptosis of multiple myeloid cells induced by polysaccharides extracts from Hedyotis diffusa and its mechanism. Zhonghua Xue Ye Xue Za Zhi. 34:337–340. 2013.(In Chinese). PubMed/NCBI

11 

Zhou QX, Liu F, Zhang JS, Lu JG, Gu ZL and Gu GX: Effects of triterpenic acid from Prunella vulgaris L. on glycemia and pancreas in rat model of streptozotozin diabetes. Chin Med J (Engl). 126:1647–1653. 2013.PubMed/NCBI

12 

Si WK, Cheng A, Li P, Liu B, Gao LH and Yao J: Study on apoptosis of human hepatoma cell line HepG2 induced by matrine. Acta Academiae Medicinae Militaris Tertiae. 23:816–820. 2001.(In Chinese).

13 

Chen XZ, Li JN, Zhang YQ, Cao ZY, Liu ZZ, Wang SQ, Liao LM and Du J: Fuzheng Qingjie recipe induces apoptosis in HepG2 cells via P38 MAPK activation and the mitochondria-dependent apoptotic pathway. Mol Med Rep. 9:2381–2387. 2014.PubMed/NCBI

14 

Lee CS and Gibson NW: DNA interstrand cross-links induced by the cyclopropylpyrroloindole antitumor agent bizelesin are reversible upon exposure to alkali. Biochemistry. 32:9108–9114. 1993. View Article : Google Scholar : PubMed/NCBI

15 

Pisani F, Sciuto R, Dessanti ML, Giannarelli D, Kayal R, Rea S, Marchesi F and Marino M: Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma. Exp Hematol Oncol. 4:172015. View Article : Google Scholar : PubMed/NCBI

16 

Fosså A, Muer M, Kasper C, Welt A, Seeber S and Nowrousian MR: Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myeloma. Leukemia. 12:422–426. 1998. View Article : Google Scholar : PubMed/NCBI

17 

Cain JM, Collins C, Petersdorf S, Figge DC, Tamimi HK, Greer BE and Livingston RB: Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer. Am J Obstet Gynecol. 174:1688–1694. 1996. View Article : Google Scholar : PubMed/NCBI

18 

Tsujii H, Kamada T, Tsuji H, Takamura A, Matsuoka Y, Usubuchi H and Irie G: Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy. Cancer. 63:1668–1672. 1989. View Article : Google Scholar : PubMed/NCBI

19 

Tang TC, Man S, Lee CR, Xu P and Kerbel RS: Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma. Neoplasia. 12:264–274. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Fraiser LH, Kanekal S and Kehrer JP: Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs. 42:781–795. 1991. View Article : Google Scholar : PubMed/NCBI

21 

Lozano GM, Bejarano I, Espino J, González D, Ortiz A, García JF, Rodríguez AB and Pariente JA: Relationship between caspase activity and apoptotic markers in human sperm in response to hydrogen peroxide and progesterone. J Reprod Dev. 55:615–621. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Taniguchi T and Minami Y: The IL-2/IL-2 receptor system: A current overview. Cell. 73:5–8. 1993. View Article : Google Scholar : PubMed/NCBI

23 

Locksley RM, Killeen N and Lenardo MJ: The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell. 104:487–501. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Cao ZY and Lan L: Experience of Professor Du Jian in fighting against gastrointestinal cancer by integrative therapy. J Fujian Univ Tradit Chin Med. 21:51–53. 2011.(In Chinese).

25 

Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK and Tang W: Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 4:297–307. 2010.PubMed/NCBI

26 

Zhang Q, Kang X and Zhao W: Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem Biophys Res Commun. 342:824–828. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Dai Z, Wan X, Kang H, Ji Z, Liu L, Liu X, Song L, Min W and Ma X: Clinical effects of shenqi fuzheng injection in the neoadjuvant chemotherapy for local advanced breast cancer and the effects on T-lymphocyte subsets. J Tradit Chin Med. 28:34–38. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Yin XM and Ding WX: Death receptor activation-induced hepatocyte apoptosis and liver injury. Curr Mol Med. 3:491–508. 2003. View Article : Google Scholar : PubMed/NCBI

29 

Nagai H, Matsumaru K, Feng G and Kaplowitz N: Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha induced apoptosis in cultured mouse hepatocytes. Hepatology. 36:55–64. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Liu H, Lo CR and Czaja MJ: NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology. 35:772–778. 2002. View Article : Google Scholar : PubMed/NCBI

31 

Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH and Gores GJ: Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest. 106:1127–1137. 2000. View Article : Google Scholar : PubMed/NCBI

32 

Owen-Schaub LB, Crump WL III, Morin GI and Grimm EA: Regulation of lymphocyte tumor necrosis factor receptors by IL-2. J Immunol. 143:2236–2241. 1989.PubMed/NCBI

33 

Lin J, Li Q, Chen H, Lin H, Lai Z and Peng J: Hedyotis diffusa Willd. extract suppresses proliferation and induces apoptosis via IL-6-inducible STAT3 pathway inactivation in human colorectal cancer cells. Oncol Lett. 9:1962–1970. 2015.PubMed/NCBI

34 

Woo HJ, do Jun Y, Lee JY, Woo MH, Yang CH and Kim YH: Apoptogenic activity of 2α,3α-dihydroxyurs-12-ene-28-oic acid from Prunella vulgaris var. lilacina is mediated via mitochondria-dependent activation of caspase cascade regulated by Bcl-2 in human acute leukemia Jurkat T cells. J Ethnopharmacol. 135:626–635. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Carrington PA, Carr TF, Stevens RF and Evans DI: Thrombocytosis associated with solid tumors in children. Pediatr Hematol Oncol. 9:289–291. 1992. View Article : Google Scholar : PubMed/NCBI

36 

Mantadakis E, Tsalkidis A and Chatzimichael A: Thrombocytosis in childhood. Indian Pediatr. 45:669–677. 2008.PubMed/NCBI

37 

Yang B, Xiao B and Sun T: Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice. Int J Biol Macromol. 62:287–290. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Sun Y, Hersh EM, Talpaz M, Lee SL, Wong W, Loo TL and Mavligit GM: Immune restoration and/or augmentation of local graft versus host reaction by traditional Chinese medicinal herbs. Cancer. 52:70–73. 1983. View Article : Google Scholar : PubMed/NCBI

39 

Sun Y, Hersh EM, Lee SL, McLaughlin M, Loo TL and Mavligit GM: Preliminary observations on the effects of the Chinese medicinal herbs Astragalus membranaceus and Ligustrum lucidum on lymphocyte blastogenic responses. J Biol Response Mod. 2:227–237. 1983.PubMed/NCBI

40 

Yue GG, Chan BC, Han XQ, Cheng L, Wong EC, Leung PC, Fung KP, Ng MC, Fan K, Sze DM and Lau CB: Immunomodulatory activities of Ganoderma sinense polysaccharides in human immune cells. Nutr Cancer. 65:765–774. 2013. View Article : Google Scholar : PubMed/NCBI

41 

Kohguchi M, Kunikata T, Watanabe H, Kudo N, Shibuya T, Ishihara T, Iwaki K, Ikeda M, Fukuda S and Kurimoto M: Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (Rokkaku-Reishi). Biosci Biotechnol Biochem. 68:881–887. 2004. View Article : Google Scholar : PubMed/NCBI

42 

Chen SM, Tsai YS, Lee SW, Liu YH, Liao SK, Chang WW and Tsai PJ: Astragalus membranaceus modulates Th1/2 immune balance and activates PPARγ in a murine asthma model. Biochem Cell Biol. 92:397–405. 2014. View Article : Google Scholar : PubMed/NCBI

43 

Wang J, Shan A, Liu T, Zhang C and Zhang Z: In vitro immunomodulatory effects of an oleanolic acid-enriched extract of Ligustrum lucidum fruit (Ligustrum lucidum supercritical CO2 extract) on piglet immunocytes. Int Immunopharmacol. 14:758–763. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Zhu X and Zhu B: Effect of Astragalus membranaceus injection on megakaryocyte hematopoiesis in anemic mice. Hua Xi Yi Ke Da Xue Xue Bao. 32:590–592. 2001.(In Chinese). PubMed/NCBI

45 

Wang GY, Li ZB, Shi JX, Wang H, Gao QF, Gen LF, Zhu JJ and Zhao QS: Oldenlandia diffusa protects against indomethacin-induced injury of the gastrointestinal mucosa in rats. Hebei J Tradit Chin Med. 23:70–71. 2001.(In Chinese).

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen XZ, Cao ZY, Zhang YQ, Li JN, Liao LM and Du J: Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice. Oncol Lett 13: 3261-3268, 2017.
APA
Chen, X., Cao, Z., Zhang, Y., Li, J., Liao, L., & Du, J. (2017). Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice. Oncology Letters, 13, 3261-3268. https://doi.org/10.3892/ol.2017.5849
MLA
Chen, X., Cao, Z., Zhang, Y., Li, J., Liao, L., Du, J."Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice". Oncology Letters 13.5 (2017): 3261-3268.
Chicago
Chen, X., Cao, Z., Zhang, Y., Li, J., Liao, L., Du, J."Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice". Oncology Letters 13, no. 5 (2017): 3261-3268. https://doi.org/10.3892/ol.2017.5849
Copy and paste a formatted citation
x
Spandidos Publications style
Chen XZ, Cao ZY, Zhang YQ, Li JN, Liao LM and Du J: Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice. Oncol Lett 13: 3261-3268, 2017.
APA
Chen, X., Cao, Z., Zhang, Y., Li, J., Liao, L., & Du, J. (2017). Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice. Oncology Letters, 13, 3261-3268. https://doi.org/10.3892/ol.2017.5849
MLA
Chen, X., Cao, Z., Zhang, Y., Li, J., Liao, L., Du, J."Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice". Oncology Letters 13.5 (2017): 3261-3268.
Chicago
Chen, X., Cao, Z., Zhang, Y., Li, J., Liao, L., Du, J."Fuzheng Qingjie granules potentiate the anticancer effect of cyclophosphamide by regulating cellular immune function and inducing apoptosis in Hepatoma 22 tumor-bearing mice". Oncology Letters 13, no. 5 (2017): 3261-3268. https://doi.org/10.3892/ol.2017.5849
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team